Position in A
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$328,262
-$56,816 QoQ
Shares Held
2,880
+1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Kovack Advisors, Inc. holds $5,774,111 across 7 Diagnostics & Research names. A ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WGS |
GeneDx Holdings Corp.
|
33,960 | $2,180,911 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
2,652 | $1,490,132 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
1,404 | $690,108 | |
| 4 | OPK |
Opko Health, Inc.
|
459,700 | $524,058 | |
| 5 | DHR |
Danaher Corp /De/
|
1,822 | $345,451 | |
| 6 | A |
Agilent Technologies, Inc.
This page
|
2,880 | $328,262 | |
| 7 | NTRA |
Natera, Inc.
|
1,076 | $215,189 |
All Filings in A
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $328,262 | 2,880 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $385,078 | 2,830 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $233,597 | 1,820 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $202,859 | 1,719 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $201,088 | 1,719 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $244,364 | 1,819 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $270,085 | 1,819 | Shares | Sole | 2024-11-05 | |
| 2021-12-31 | $254,162 | 1,592 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $247,794 | 1,573 | Shares | Sole | 2021-11-03 | |
| No filing history on record for this holder in this stock. | ||||||